| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,245 |
7,094 |
$493K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,735 |
7,640 |
$334K |
| 96910 |
|
4,904 |
1,062 |
$301K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
6,938 |
6,899 |
$274K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,083 |
4,083 |
$248K |
| 11102 |
|
3,466 |
3,420 |
$184K |
| 17110 |
|
2,537 |
2,194 |
$155K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,306 |
1,303 |
$126K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,115 |
3,059 |
$80K |
| 11103 |
|
931 |
913 |
$49K |
| 17000 |
|
1,152 |
1,143 |
$32K |
| 11100 |
|
491 |
472 |
$25K |
| 11900 |
|
914 |
904 |
$24K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,922 |
1,664 |
$15K |
| 11901 |
|
278 |
257 |
$10K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
157 |
153 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,965 |
1,903 |
$3K |
| 17003 |
|
210 |
207 |
$2K |
| 17111 |
|
23 |
15 |
$2K |
| 11101 |
|
34 |
28 |
$598.65 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
18 |
14 |
$182.18 |
| G8482 |
Influenza immunization administered or previously received |
585 |
560 |
$0.00 |
| 4004F |
|
64 |
63 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
1,449 |
1,398 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
520 |
495 |
$0.00 |
| G9991 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
32 |
31 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,129 |
2,034 |
$0.00 |
| G9989 |
Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine) |
144 |
134 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
804 |
779 |
$0.00 |
| 1036F |
|
2,556 |
2,452 |
$0.00 |
| G2181 |
Bmi not documented due to medical reason or patient refusal of height or weight measurement |
27 |
27 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
13 |
13 |
$0.00 |